NEWS
RESOURCES
PODCAST
Donate
Subscribe
Search

Glatiramer acetate (Copaxone®) in the form of a pre-filled pen to PBAC, March 2022

view submission

<meta http-equiv="refresh" content="0; URL=https://www.msaustralia.org.au/wp-content/uploads/2022/06/glatiramer-acetate-copaxone-pre-filled-pen.pdf" />

MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT
Read More
Joint Standing Committee on the NDIS inquiry into the future of the NDIS
Submission to the Australian National Audit Office’s performance audit of the Australian Government Department of Health’s management of the expansion of telehealth services in response to the COVID-19 pandemic

Newsletter subscription

  • Enter your details

Glatiramer acetate (Copaxone®) in the form of a pre-filled pen to PBAC, March 2022